Literature DB >> 16875667

Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis.

Zhengrong Li1, Wenhua Zhan, Zhao Wang, Baohe Zhu, Yulong He, Junsheng Peng, Shirong Cai, Jinping Ma.   

Abstract

High expression of PRL-3, a protein tyrosine phosphatase, is proved to be associated with lymph node metastasis in gastric carcinoma from previous studies. In this paper, we examined the relationship between PRL-3 expression and peritoneal metastasis in gastric carcinoma. We applied the artificial miRNA (pCMV-PRL3miRNA), which is based on the murine miR-155 sequence, to efficiently silence the target gene expression of PRL-3 in SGC7901 gastric cancer cells at both mRNA and protein levels. Then we observed that, in vitro, pCMV-PRL3miRNA significantly depressed the SGC7901 cell invasion and migration independent of cellular proliferation. In vivo, PRL-3 knockdown effectively suppressed the growth of peritoneal metastases and improved the prognosis in nude mice. Therefore, we concluded that artificial miRNA can depress the expression of PRL-3, and that PRL-3 might be a potential therapeutic target for gastric cancer peritoneal metastasis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16875667     DOI: 10.1016/j.bbrc.2006.07.043

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  42 in total

1.  Lentivirus-mediated RNA silencing of c-Met markedly suppresses peritoneal dissemination of gastric cancer in vitro and in vivo.

Authors:  Xiao-lei Wang; Xi-mei Chen; Jian-ping Fang; Chang-qin Yang
Journal:  Acta Pharmacol Sin       Date:  2012-03-12       Impact factor: 6.150

Review 2.  MicroRNAs in skin and wound healing.

Authors:  Jaideep Banerjee; Yuk Cheung Chan; Chandan K Sen
Journal:  Physiol Genomics       Date:  2010-10-19       Impact factor: 3.107

3.  A simple array platform for microRNA analysis and its application in mouse tissues.

Authors:  Xiaoqing Tang; Jozsef Gal; Xun Zhuang; Wangxia Wang; Haining Zhu; Guiliang Tang
Journal:  RNA       Date:  2007-08-03       Impact factor: 4.942

Review 4.  Advances in microRNAs: implications for gene therapists.

Authors:  Rebecca T Marquez; Anton P McCaffrey
Journal:  Hum Gene Ther       Date:  2008-01       Impact factor: 5.695

Review 5.  Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell.

Authors:  Georgia Sotiropoulou; Georgios Pampalakis; Evi Lianidou; Zissimos Mourelatos
Journal:  RNA       Date:  2009-06-26       Impact factor: 4.942

Review 6.  Regulatory Mechanisms and Novel Therapeutic Targeting Strategies for Protein Tyrosine Phosphatases.

Authors:  Zhi-Hong Yu; Zhong-Yin Zhang
Journal:  Chem Rev       Date:  2017-05-25       Impact factor: 60.622

7.  Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.

Authors:  Yunpeng Bai; Zhi-Hong Yu; Sijiu Liu; Lujuan Zhang; Ruo-Yu Zhang; Li-Fan Zeng; Sheng Zhang; Zhong-Yin Zhang
Journal:  Cancer Res       Date:  2016-06-20       Impact factor: 12.701

8.  Tissue-specific alterations of PRL-1 and PRL-2 expression in cancer.

Authors:  Carmen M Dumaual; George E Sandusky; Han Weng Soo; Sean R Werner; Pamela L Crowell; Stephen K Randall
Journal:  Am J Transl Res       Date:  2012-01-05       Impact factor: 4.060

9.  A novel expression system for artificial miRNAs containing no endogenous miRNA precursor sequences.

Authors:  Atsushi Shibata; Akiko Iwaki; Yasuyuki Fukumaki
Journal:  J RNAi Gene Silencing       Date:  2007-05-27

10.  PRL-3 promotes the motility, invasion, and metastasis of LoVo colon cancer cells through PRL-3-integrin beta1-ERK1/2 and-MMP2 signaling.

Authors:  Lirong Peng; Xiaofang Xing; Weijun Li; Like Qu; Lin Meng; Shenyi Lian; Beihai Jiang; Jian Wu; Chengchao Shou
Journal:  Mol Cancer       Date:  2009-11-24       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.